ClinicalTrials.govpublic full text
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
hiv infections, phase 3, randomized, open-label, treatment-experienced, highly active antiretroviral therapy, hiv, tenofovir df, pediatrics, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873408
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.